首页> 外文期刊>中华创伤杂志(英文版) >Protective effect of ischemic postconditioning on lung ischemia-reperfusion injury in rats and the role of heme oxygenase-1
【24h】

Protective effect of ischemic postconditioning on lung ischemia-reperfusion injury in rats and the role of heme oxygenase-1

机译:缺血后处理对大鼠肺缺血再灌注损伤的保护作用及血红素加氧酶-1的作用

获取原文
获取原文并翻译 | 示例
           

摘要

To investigate the effect of ischemic postconditioning (IPO) on acute lung ischemia-reperfusion (I/R) injury and the protein expression of haeme oxygenase-1 (H0-1), a cytoprotective defense against oxidative injury. Methods: After being anesthetized with chloralhy-drate, forty-eight healthy SD rats were randomly divided into 6 groups (8 in each): sham operation group (S group); I/R group: left lung hilum was clamped for 40 minutes followed by 105 minutes of reperfusion; IPO group: left lung hilum was clamped for40 minutes and postconditioned by 3 cycles of 30 seconds of reperfusion and 30 seconds of reocclusion; Hemin (HM)+ I/R group: hemin, an inducer of HO- 1 was injected intraperitoneally at 40 μmol.kg-1·day-1 for two con-secutive days prior to 40 minutes clamping of left lung hilum; ZnPPIX+IPO group: zinc protoporphyrin Ⅸ, an inhibitor of HO-1 was injected intraperitoneally at 20 mg·kg-1 24 hours prior to 40 minutes clamping of left lung hilum; and HM+S group: HM was administered as in the HM+I/R group without inducing lung I/R. Arterial partial pressure of oxygen (PaO2) and malondialdehyde (MDA) content in serum were assessed. The left lung was removed for determination of wet/dry lung weight ratio and expression of HO-1 protein by immuno-his-tochemical technique and for light microscopic examination. Results: The PaO2 was significantly lower in all the experimental groups compared with sham group (90 mm Hg ±11 mm Hg). However, the values ofPaO2 in IPO (81 mm Hg ±7 mm Hg) and HM+I/R (80 mm Hg±9 mm Hg) were higher than that in I/R (63 mm Hg±9 mm Hg) and ZnPPIX+IPO (65 mm Hg±8 mm Hg) groups (P<0.01). The protein expression of HO-1 in lung tissue was significantly increased in I/R group compared with S group (P<0.01). While the HO-1 protein expression was higher in IPO and HM+I/R groups as compared with I/R group (P<0.05, P<0.01). The lung wet/ dry (W/D) weight ratio and MDA content in serum were significantly increased in I/R group as compared with S or HM+S groups (P<0.01), accompanied by severe lung tissue histological damage, which was attenuated either by IPO or by HM pretreatment (P<0.01, IPO or HM+I/R vs. I/R). The protective effect of IPO was abolished by ZnPPIX. Condusion: Ischemic postconditioning can attenuate the lung ischemia-reperfusion injury through upregulating the protein expression of HO-1 that leads to reduced post-ischemic oxidative damage.
机译:要研究缺血后处理(IPO)对急性肺缺血-再灌注(I / R)损伤和血红素加氧酶-1(H0-1)的蛋白表达的作用,血红素加氧酶-1(H0-1)是一种抗氧化损伤的细胞保护防御剂。方法:将48只健康SD大鼠用氯醛麻醉后,随机分为6组(每组8只):假手术组(S组);假手术组(S组)。 I / R组:将左肺门钳40分钟,然后再灌注105分钟; IPO组:将左肺门钳紧40分钟,并通过30次再灌注和30秒再闭塞的3个周期进行后处理;血红素(HM)+ I / R组:连续40天连续40天以40μmol.kg-1·day-1腹膜内注射HO-1诱导剂血红素; ZnPPIX + IPO组:在左肺门闭塞40分钟前24小时,以20 mg·kg-1腹膜内注射HO-1抑制剂原卟啉锌。 HM + S组:与HM + I / R组相同,不引起肺I / R。评估血清中的动脉血氧分压(PaO2)和丙二醛(MDA)含量。取出左肺,通过免疫组化技术测定肺干/湿重比和HO-1蛋白的表达,并进行光学显微镜检查。结果:与假手术组(90 mm Hg±11 mm Hg)相比,所有实验组的PaO2均显着降低。但是,IPO(81 mm Hg±7 mm Hg)和HM + I / R(80 mm Hg±9 mm Hg)中的PaO2值高于I / R(63 mm Hg±9 mm Hg)和ZnPPIX + IPO(65 mm Hg±8 mm Hg)组(P <0.01)。与S组比较,I / R组肺组织中HO-1的蛋白表达明显升高(P <0.01)。 IPO组和HM + I / R组HO-1蛋白表达均高于I / R组(P <0.05,P <0.01)。与S组或HM + S组相比,I / R组的肺干/湿(W / D)重量比和血清中MDA含量显着增加(P <0.01),并伴有严重的肺组织组织学损伤,这是因为通过IPO或HM预处理减弱(P <0.01,IPO或HM + I / R vs.I / R)。 ZnPPIX取消了IPO的保护作用。结论:缺血后处理可通过上调HO-1的蛋白表达来减轻肺缺血再灌注损伤,从而减少缺血后氧化损伤。

著录项

  • 来源
    《中华创伤杂志(英文版)》 |2009年第3期|162-166|共5页
  • 作者单位

    Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan 430060, China;

    Department of Anesthesiology, Xiangfan Central Hospital, Xiangfan 441021, Hubei, China;

    Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan 430060, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 外科学;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号